Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 42, 2012 - Issue 3
148
Views
3
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

ϵ-Acetamidocaproic acid pharmacokinetics in rats with gastric ulcer or small bowel inflammation

, , , , &
Pages 310-315 | Received 03 Jul 2011, Accepted 28 Aug 2011, Published online: 12 Oct 2011
 

Abstract

  1. The pharmacokinetics of ϵ-acetamidocaproic acid (AACA) were evaluated after the intravenous and oral administration of an antiulcer agent, zinc acexamate (ZAC) at a dose of 20 mg kg−1 (ion pairing between zinc and AACA) in rats with indomethacin-induced acute gastric ulcer (IAGU) or indomethacin-induced small bowel inflammation (ISBI).

  2. In IAGU rats, the area under the curves (AUCs) of AACA were significantly smaller after both the intravenous (551 versus 1270 μg min ml−1) and oral (397 versus 562 μg min ml−1) administration of ZAC than controls, possible due to the significantly faster CLR of AACA. In ISBI rats, however, the AUCs of AACA were comparable with controls after both the intravenous and oral administration of ZAC.

  3. In IAGU rats, the significantly smaller AUCs of AACA were due to the significantly faster CLR (due to the decreased urinary pH by indomethacin treatment) than controls. AACA has a basic secondary amine group. On the other hand, the comparable AUCs of AACA in ISBI rats were due to the comparable CLRs between ISBI and control rats.

  4. AACA was excreted in the urine via active renal tubular secretion in all rats studied.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.